Literature DB >> 7300105

Chemical characterization of glomerular and tubular basement membranes of men of different age.

J P Langeveld, J H Veerkamp, C M Duyf, L H Monnens.   

Abstract

Pairs of glomerular and tubular basement membrane preparations were obtained from kidneys of individuals of premature age up to 80 years. The purity of the preparations was established with light and electron microscopy and by estimating the total phosphorus content. The amino acid and carbohydrate composition was determined and statistically evaluated for 33 to 38 preparations divided over five age groups. Comparison of glomerular and tubular basement membranes from the same kidneys showed that regardless of age glomerular basement membranes contain more 3-hydroxyproline and more of the heteropolysaccharide constituents neuraminic acids and mannose. These differences cannot be ascribed solely to the presence of a minor amount of interstitial collagen. The chemical composition of the two types of basement membranes changes with age. For the first few years after birth the contents of glycine and total imino acids increase and those of collagen-nonspecific amino acids decrease, whereas constituents of the heteropolysaccharide units do not change markedly. These results suggest that proportions of collagenous and noncollagenous peptide moieties gradually change with age in both glomerular and tubular basement membranes. In addition, the extent of hydroxylation of proline and lysine increases significantly with age, reaching an adult level for glomerular basement membranes after 4 to 7 months of age and for tubular basement membranes during late childhood. The contents of glucose and galactose rise with age to an extent comparable with that of hydroxylysine. The age-related changes in basement membrane composition may influence functional properties of these extracellular renal structures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300105     DOI: 10.1038/ki.1981.111

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.

Authors:  P Heeringa; E Brouwer; P A Klok; M G Huitema; J van den Born; J J Weening; C G Kallenberg
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV.

Authors:  B Cederholm; J Wieslander; P Bygren; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Development and heterogeneity of antigens in the immature nephron. Reactivity with human antiglomerular basement membrane autoantibodies.

Authors:  K Jeraj; A J Fish; K Yoshioka; A F Michael
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

4.  Renal allograft rejection: possible involvement of lymphokine-activated killer cells.

Authors:  J A Kirby; J L Forsythe; G Proud; R M Taylor
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

5.  The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type.

Authors:  L P Van den Heuvel; J Van den Born; H Jalanko; C H Schröder; J H Veerkamp; K J Assmann; J H Berden; C Holmberg; J Rapola; L A Monnens
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

6.  Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep.

Authors:  Jan P M Langeveld; Jorg G Jacobs; Jo H F Erkens; Alex Bossers; Fred G van Zijderveld; Lucien J M van Keulen
Journal:  BMC Vet Res       Date:  2006-06-09       Impact factor: 2.741

7.  Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.

Authors:  Ramesh Tati; Ann-Charlotte Kristoffersson; Minola Manea Hedström; Matthias Mörgelin; Jörgen Wieslander; Cees van Kooten; Diana Karpman
Journal:  EBioMedicine       Date:  2017-01-24       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.